DIN 02467879 — TRESIBA 100 UNIT
TRESIBA is a solution of Insulin Degludec marketed by NOVO NORDISK CANADA INC. The full Insulin Degludec monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02467879
- Brand name
- TRESIBA
- Active ingredient
- Insulin Degludec
- Strength
- 100 UNIT
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- NOVO NORDISK CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Long-acting basal insulin analogue (antidiabetic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Insulin Degludec products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02467860 | TRESIBA | 100 UNIT | SOLUTION | NOVO NORDISK CANADA INC | MARKETED |
| 02467887 | TRESIBA | 200 UNIT | SOLUTION | NOVO NORDISK CANADA INC | MARKETED |